Watch MD. Know when insiders buy.
One email the day a filing lands. Free.
MD
Pediatrix Medical Group, Inc.
28.10
+0.02 +0.07%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
57
WATCH · shorts 57
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
1 / 15
tracked funds hold it
Calls on record
0
nobody we score has called it yet
MKT CAP $2.3BP/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME $174.8M +59.0%NET DEBT $322.3M52W 16.97 – 28.10SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | $56.9M | $39.8M | +1.5% | — | $125.3M | — | — | Aug 4 |
| Q1 2026 · Mar 31 | — | — | — | $41.7M | $29.6M | +42.6% | — | −$129.8M | — | — | Aug 4 |
| Q4 2025 · Dec 31derived | — | — | — | $48.8M | $33.7M | +10.5% | — | $114.1M | — | — | May 5 |
| Q3 2025 · Sep 30 | — | — | — | $68.1M | $71.7M | +268.8% | — | $137.3M | — | — | Nov 3 |
| Q2 2025 · Jun 30 | — | — | — | $59.9M | $39.3M | — | — | $137.2M | — | — | Aug 4 |
| Q1 2025 · Mar 31 | — | — | — | $32.1M | $20.7M | +413.9% | — | −$117.5M | — | — | Aug 4 |
| Q4 2024 · Dec 31derived | — | — | — | $39.3M | $30.5M | — | — | $133M | — | — | Feb 19 |
| Q3 2024 · Sep 30 | — | — | — | $33.8M | $19.4M | −9.1% | — | $91.8M | — | — | Nov 3 |
| Q2 2024 · Jun 30 | — | — | — | −$157.7M | −$153M | — | — | $107M | — | — | Nov 3 |
| Q1 2024 · Mar 31 | — | — | — | $15.9M | $4M | — | — | −$125.2M | — | — | Nov 3 |
| Q4 2023 · Dec 31derived | — | — | — | −$111.5M | −$124.3M | — | — | $69.3M | — | — | Feb 19 |
| Q3 2023 · Sep 30 | — | — | — | $40.3M | $21.4M | — | — | $79.9M | — | — | Nov 1 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | $208.8M | $165.4M | — | — | $271.1M | — | — | $86.7M | — |
| FY2024 · to Dec 31 | — | — | −$68.7M | −$99.1M | — | — | $206.6M | — | — | $1.7M | — |
| FY2023 · to Dec 31 | — | — | $7.3M | −$60.4M | — | — | $137.3M | — | — | $919K | — |
| FY2022 · to Dec 31 | — | — | $172.7M | $66.3M | — | — | $166.9M | — | — | $88.5M | — |
| FY2021 · to Dec 31 | — | — | $202.9M | $131M | — | — | $76.7M | — | — | $4.7M | — |
| FY2020 · to Dec 31 | — | — | $98.1M | −$796.5M | — | — | $204.6M | — | — | $8.5M | — |
Every number comes from Pediatrix Medical Group, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.